Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$98.32 USD

98.32
21,578,090

-0.84 (-0.85%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.81 +0.49 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (106 out of 247)

Industry: Medical Services

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Benjamin Rains headshot

Should You Buy Walgreens Boots (WBA) Stock Ahead of Q4 Earnings?

Walgreens Boots Alliance (WBA) shares have surged 17% in the last three months to outpace the S&P 500's roughly 7% climb as fears that Amazon's (AMZN) pharmaceutical push would doom the pharmacy giant prove overblown. Now the question is should investors consider buying WBA stock ahead of its Q4 earnings release on October 11?

    Mark Vickery headshot

    Top Research Reports for Adobe, United Technologies & Lockheed Martin

    Today's Research Daily features new research reports on 16 major stocks, including Adobe (ADBE), United Technologies (UTX) and Lockheed Martin (LMT).

      Zacks Equity Research

      Here's Why You Should Invest in CVS Health (CVS) Stock Now

      CVS Health's (CVS) solid cash position is encouraging. Strong 2019 PBM selling season is another upside.

        Zacks Equity Research

        Is CVS Health (CVS) Stock Undervalued Right Now?

        Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

          Zacks Equity Research

          Cigna Gets Merger Nod, Forms Management for Unified Entity

          Cigna (CI) forms management as it prepares for new merged entity.

            Zacks Equity Research

            WellCare Health's (WCG) Buyout to Expand Medicare Business

            WellCare Health's (WCG) impending buyout of Aetna's Medicare business to expand and cement its foothold in the rapidly growing market.

              Zacks Equity Research

              Aetna a Step Closer to CVS Merger, Sells Medicare Business

              Aetna (AET) gets a step closer to its merger with CVS Health by selling its Medicare business to WellCare Health.

                Ritujay Ghosh headshot

                Are M&As Helping U.S. Markets Amid Trade War Fears?

                This year so far has already seen quite a few big acquisitions, which is helping the broader market.

                  Sweta Jaiswal headshot

                  3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

                  With the hurricane season at the peak, we bring three safe picks for investors.

                    Zacks Equity Research

                    Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

                    Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.